Fertirelin
Appearance
Clinical data | |
---|---|
Trade names | Ovalyse |
Other names | TAP-031; U-69689; 9-(N-Ethyl-L-prolinamide)-10-deglycinamide; 9-(N)-Et-ProNH2-10-des-GlyNH2-LHRH; Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-NHEt |
Drug class | GnRH analogue; GnRH agonist; Antigonadotropin |
ATCvet code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.164.570 |
Chemical and physical data | |
Formula | C55H76N16O12 |
Molar mass | 1153.313 g·mol−1 |
3D model (JSmol) | |
| |
|
Fertirelin, or fertirelin acetate, sold under the brand name Ovalyse, is a gonadotropin-releasing hormone agonist (GnRH agonist) which has been marketed in the United Kingdom and Austria.[1][2][3] It may no longer be available.[4] Fertirelin has been used in veterinary medicine.[2] It may have been used in the treatment of sex hormone-dependent conditions and infertility in women.[3] The drug was first introduced in 1981 in Japan to treat various kinds of ovarian failure in cattle.[5] Fertirelin is a synthetic peptide and GnRH analogue.[1][2] It is used as the acetate salt.[2]
See also
References
- ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 549–. ISBN 978-1-4757-2085-3.
- ^ a b c d Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 441–. ISBN 978-3-88763-075-1.
- ^ a b I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 120–. ISBN 978-94-011-4439-1.
- ^ https://www.drugs.com/international/fertirelin.html
- ^ Okada J, Seo T, Kasahara F, Takeda K, Kondo S (1991). "New degradation product of des-Gly10-NH2-LH-RH-ethylamide (fertirelin) in aqueous solution". J Pharm Sci. 80 (2): 167–70. doi:10.1002/jps.2600800217. PMID 2051323.